Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395 |
filingDate |
1995-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_409c19b25b481028306447cd97a0d225 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a56cd250a316a33ab7ad6f1123ef5af2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_451aedb7f530d1e6afbe6144bec87a7c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e308c3804a3f02ad1268aa221d07e5d |
publicationDate |
1995-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
HU-211559-A9 |
titleOfInvention |
Imidazolidyl Macrolides with Immunosuppressive Effects Transition protection is described in Figures 1-13. claims. |
priorityDate |
1995-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |